The important role of CROs in shaping the future of clinical research across Europe
Excerpt from the Article:
It goes without saying that COVID-19 has had a tremendous impact on our global society and economy.
In fact, as lockdown was initiated across Europe at the start of March, we quickly saw the impact of this pandemic on clinical research activities across the various regions. Within the life sciences industry, we were confronted with challenges not experienced before, which have resulted in an acceleration of innovation across many areas, most notably the increasing need for digital and virtual capabilities to enable continuity of service.
The life sciences industry has traditionally been more cautious and reticent in its approach to adopting virtual trial capabilities. This is both understandable and evident when you look at particular therapeutic areas such as ophthalmology where there is dependence on device-led diagnosis and treatment, adding complexity to the evolution of virtual and remote offerings. What’s more, the existing model and processes have long been accepted and have a proven track record and history of success.
Click the button below to continue reading the Article:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?